Amato R - Search Results

1

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.

Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D, Vokes EE. Stadler WM, et al. Among authors: amato r. J Clin Oncol. 2000 Jan;18(2):371-5. doi: 10.1200/JCO.2000.18.2.371. J Clin Oncol. 2000. PMID: 10637252 Clinical Trial.

2

A molecular classification of papillary renal cell carcinoma.

Yang XJ, Tan MH, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT. Yang XJ, et al. Among authors: amato r. Cancer Res. 2005 Jul 1;65(13):5628-37. doi: 10.1158/0008-5472.CAN-05-0533. Cancer Res. 2005. PMID: 15994935

3

Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma.

Amato RJ, Malya R, Rawat A. Amato RJ, et al. Am J Clin Oncol. 2008 Jun;31(3):237-43. doi: 10.1097/COC.0b013e31815e4505. Am J Clin Oncol. 2008. PMID: 18525301 Clinical Trial.

4

Lenalidomide therapy for metastatic renal cell carcinoma.

Amato RJ, Hernandez-McClain J, Saxena S, Khan M. Amato RJ, et al. Am J Clin Oncol. 2008 Jun;31(3):244-9. doi: 10.1097/COC.0b013e31815e451f. Am J Clin Oncol. 2008. PMID: 18525302 Clinical Trial.

5

Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Fitz K, Amato R, Reuben JM, Dozier N. Dexeus FH, et al. Among authors: amato r. J Clin Oncol. 1990 Feb;8(2):325-9. doi: 10.1200/JCO.1990.8.2.325. J Clin Oncol. 1990. PMID: 2137163

6

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: amato r. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

7

Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study.

Bukowski R, Ernstoff MS, Gore ME, Nemunaitis JJ, Amato R, Gupta SK, Tendler CL. Bukowski R, et al. Among authors: amato r. J Clin Oncol. 2002 Sep 15;20(18):3841-9. doi: 10.1200/JCO.2002.02.051. J Clin Oncol. 2002. PMID: 12228203 Clinical Trial.

8

A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma.

Amato R, Meyers C, Ellerhorst J, Finn L, Kilbourn R, Sella A, Logothetis C. Amato R, et al. Ann Oncol. 1995 Nov;6(9):911-4. doi: 10.1093/oxfordjournals.annonc.a059358. Ann Oncol. 1995. PMID: 8624294 Free article. Clinical Trial.

9

Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.

Amato RJ, Hawkins RE, Kaufman HL, Thompson JA, Tomczak P, Szczylik C, McDonald M, Eastty S, Shingler WH, de Belin J, Goonewardena M, Naylor S, Harrop R. Amato RJ, et al. Clin Cancer Res. 2010 Nov 15;16(22):5539-47. doi: 10.1158/1078-0432.CCR-10-2082. Epub 2010 Sep 29. Clin Cancer Res. 2010. PMID: 20881001 Clinical Trial.

10

Irofulven, a novel inhibitor of DNA synthesis, in metastatic renal cell cancer.

Amato RJ, Perez C, Pagliaro L. Amato RJ, et al. Invest New Drugs. 2002 Nov;20(4):413-7. doi: 10.1023/a:1020649827173. Invest New Drugs. 2002. PMID: 12448659 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

744 results

Search Page

Filters